Cargando…
艾曲泊帕治疗再生障碍性贫血的疗效与安全性:中国多中心调查结果
OBJECTIVE: To evaluate the safety and efficacy of eltrombopag combined with immunosuppressive therapy in patients with aplastic anemia (AA) in China. METHODS: We investigated and analyzed the clinical data of AA patients from 14 hematological treatment centers who were treated with oral eltrombopag...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767810/ https://www.ncbi.nlm.nih.gov/pubmed/33333690 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2020.11.002 |
Ejemplares similares
-
阿伐曲泊帕转换治疗TPO受体激动剂难治性再生障碍性贫血疗效及安全性
Publicado: (2022) -
艾曲泊帕、重组人血小板生成素联合标准免疫抑制治疗重型再生障碍性贫血16例疗效及安全性分析
Publicado: (2021) -
艾曲波帕联合环孢素A治疗极重型再生障碍性贫血一例
Publicado: (2019) -
艾曲泊帕治疗成人慢性原发免疫性血小板减少症的疗效及安全性
Publicado: (2018) -
阿伐曲泊帕联合标准免疫抑制治疗伴肝损害的重型再生障碍性贫血6例
Publicado: (2022)